Renal effects of levosimendan: a consensus report
Clicks: 260
ID: 271562
2013
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
260 views
39 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #8 of 22 articles by views in cardiovascular drugs and therapy
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Renal dysfunction is common in clinical settings in which cardiac function is compromised such as heart failure, cardiac surgery or sepsis, and is associated with high morbidity and mortality. Levosimendan is a calcium sensitizer and potassium channel opener used in the treatment of acute heart fail …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (46 words).
Try re-searching for a better abstract.
| Reference Key |
mb2013cardiovascularrenal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Yilmaz MB;Grossini E;Silva Cardoso JC;Édes I;Fedele F;Pollesello P;Kivikko M;Harjola VP;Hasslacher J;Mebazaa A;Morelli A;le Noble J;Oldner A;Oulego Erroz I;Parissis JT;Parkhomenko A;Poelzl G;Rehberg S;Ricksten SE;Rodríguez Fernández LM;Salmenperä M;Singer M;Treskatsch S;Vrtovec B;Wikström G;; |
| Journal | cardiovascular drugs and therapy |
| Year | 2013 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
review
animals
humans
pubmed abstract
nih
national institutes of health
national library of medicine
Cardiotonic Agents / pharmacology*
kidney / drug effects*
simendan
hydrazones / pharmacology*
pyridazines / pharmacology*
pmid:23929366
pmc3830192
doi:10.1007/s10557-013-6485-6
mehmet b yilmaz
elena grossini
gerhard wikström
kidney / physiology
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.